Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochemical Pharmacology

• Publication date

  2014-12-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2014.09.027PMID 25450672PMCID PMC4314359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel immunomodulatory effect of ugonin U in human neutrophils via stimulation of phospholipase C.

  2014cited by this paper
• Estrogen biology: new insights into GPER function and clinical opportunities.

  2014cited by this paper
• Development of potent antagonists for formyl peptide receptor 1 based on Boc-Phe-D-Leu-Phe-D-Leu-Phe-OH.

  2014cited by this paper
• Neutrophil isolation from nonhuman species.

  2014cited by this paper
• Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer.

  2014cited by this paper
• Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

  2014cited by this paper
• Selective Agonists and Antagonists of Formylpeptide Receptors: Duplex Flow Cytometry and Mixture-Based Positional Scanning Libraries

  2013cited by this paper
• 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.

  2013cited by this paper
• Afrormosin, an Isoflavonoid from Amburana cearensis A. C. Smith, Modulates the Inflammatory Response of Stimulated Human Neutrophils

  2013cited by this paper
• Inhibitory effect of Crotalus durissus terrificus venom on chronic edema induced by injection of bacillus Calmette-Guérin into the footpad of mice.

  2013cited by this paper
• Molecular biology for formyl peptide receptors in human diseases

  2013cited by this paper
• Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation.

  2013cited by this paper
• Reperfusion‐induced myocardial dysfunction is prevented by endogenous annexin‐A1 and its N‐terminal‐derived peptide Ac‐ANX‐A12‐26

  2013cited by this paper
• On the radical scavenging activity of isoflavones: thermodynamics of O-H bond cleavage.

  2013cited by this paper
• Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries

  2013cited by this paper
• Soy and its isoflavones: the truth behind the science in breast cancer.

  2013cited by this paper
• V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins

  2013cited by this paper
• Design and synthesis of tryptophan containing dipeptide derivatives as formyl peptide receptor 1 antagonist.

  2013cited by this paper
• Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function.

  2013cited by this paper
• Disposition of pharmacologically active dietary isoflavones in biological systems.

  2013cited by this paper
• A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.

  2012cited by this paper
• G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma.

  2012cited by this paper
• Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice.

  2012cited by this paper
• Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1

  2012cited by this paper
• Lead optimisation of pyrazoles as novel FPR1 antagonists.

  2012cited by this paper
• Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1‐FPR2/ALX anti‐inflammatory system

  2012cited by this paper
• Genistein regulates the IL-1 beta induced activation of MAPKs in human periodontal ligament cells through G protein-coupled receptor 30.

  2012cited by this paper
• Glucocorticoid excess and disturbed hemodynamics in advanced age: the extent to which soy isoflavones may be beneficial.

  2012cited by this paper
• Discovery of pyrazoles as novel FPR1 antagonists.

  2011cited by this paper
• Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents.

  2011cited by this paper
• High content pharmacophores from molecular fields: a biologically relevant method for comparing and understanding ligands.

  2011cited by this paper
• Baicalin, a flavonoid from Scutellaria baicalensis Georgi, activates large-conductance Ca2+-activated K+ channels via cyclic nucleotide-dependent protein kinases in mesenteric artery.

  2010cited by this paper
• Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.

  2010cited by this paper
• The Annexin I Sequence Gln9-Ala10-Trp11-Phe12 Is a Core Structure for Interaction with the Formyl Peptide Receptor 1*

  2010cited by this paper
• Acetogenin and prenylated flavonoids from Helminthostachys zeylanica with inhibitory activity on superoxide generation and elastase release by neutrophils.

  2010cited by this paper
• Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors.

  2010cited by this paper
• Identification of Novel Small-Molecule Agonists for Human Formyl Peptide Receptors and Pharmacophore Models of Their Recognition

  2010cited by this paper
• Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?

  2010cited by this paper
• Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.

  2010cited by this paper
• Synthetic derivatives of genistein, their properties and possible applications.

  2010cited by this paper
• Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation.

  2009cited by this paper
• Mycobacteria Attenuate Nociceptive Responses by Formyl Peptide Receptor Triggered Opioid Peptide Release from Neutrophils

  2009cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

  2009cited by this paper
• Duplex high‐throughput flow cytometry screen identifies two novel formylpeptide receptor family probes

  2009cited by this paper
• Isoflavones are safe compounds for therapeutical applications – Evaluation of in vitro data

  2009cited by this paper
• Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30.

  2009cited by this paper
• Discovery of small molecule human FPR1 receptor antagonists.

  2009cited by this paper
• Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes

  2009cited by this paper
• A novel fluorescent cross‐reactive formylpeptide receptor/formylpeptide receptor‐like 1 hexapeptide ligand

  2009cited by this paper
• Flavonoids: prospective drug candidates.

  2008cited by this paper
• Inhibition by soya isoflavones of human polymorphonuclear leukocyte function: possible relevance for the beneficial effects of soya intake

  2008cited by this paper
• Erratum: Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1 (Molecular Pharmacology (2007) 72 (976-983))

  2007cited by this paper
• Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1

  2007cited by this paper
• Neutrophil isolation from nonhuman species.

  2007cited by this paper
• Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.

  2007cited by this paper
• High-Throughput Screening for Small-Molecule Activators of Neutrophils: Identification of Novel N-Formyl Peptide Receptor Agonists

  2007cited by this paper
• Isoflavonoids of the leguminosae.

  2007influential reference
• The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.

  2007cited by this paper
• Isoflavonoids of the leguminosae.

  2007cited by this paper
• Cyclosporin H, Boc-MLF and Boc-FLFLF are Antagonists that Preferentially Inhibit Activity Triggered Through the Formyl Peptide Receptor

  2007cited by this paper
• Molecular field technology applied to virtual screening and finding the bioactive conformation

  2007cited by this paper
• Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro.

  2006cited by this paper
• Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method.

  2006cited by this paper
• Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation

  2006cited by this paper
• Involvement of Rho signaling in PAR2-mediated regulation of neutrophil adhesion to lung epithelial cells.

  2006cited by this paper
• Response to genistein: assaying the activation status and chemotaxis efficacy of isolated neutrophils.

  2006cited by this paper
• Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.

  2006cited by this paper
• Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein.

  2005cited by this paper
• Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonistss⃞

  2005cited by this paper
• High-Throughput Screening with HyperCyt® Flow Cytometry to Detect Small Molecule Formylpeptide Receptor Ligands

  2005cited by this paper
• Stimulation of cellular free Ca2+ elevation and inhibition of store-operated Ca2+ entry by kazinol B in neutrophils

  2004cited by this paper
• Effect of S-(1,2-Dicarboxyethyl) Glutathione and S-(1,2-Dicarboxyethyl) Cysteine on the Stimulus-Induced Superoxide Generation and Tyrosyl Phosphorylation of Proteins in Human Neutrophils

  2002cited by this paper
• Pharmacological analysis for mechanisms of GPI‐80 release from tumour necrosis factor‐α‐stimulated human neutrophils

  2002cited by this paper
• Impaired Antibacterial Host Defense in Mice Lacking the N-formylpeptide Receptor

  1999cited by this paper
• Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases.

  1995cited by this paper
• Extended electron distributions applied to the molecular mechanics of some intermolecular interactions

  1994cited by this paper
• Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases.

  1993cited by this paper
• Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

  1992cited by this paper
• Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils.

  1992influential reference
• Effects of tenoxicam on superoxide anion formation, beta-glucuronidase release and fMLP binding in human neutrophils: comparison with other NSAIDs.

  1991cited by this paper
• The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+/calmodulin dependent EF-2 phosphorylation in vitro.

  1988cited by this paper
• Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils

  1982cited by this paper
• N-formylmethionyl peptides as chemoattractants for leucocytes.

  1975cited by this paper

• Formylpeptide receptors in GtoPdb v.2025.3

  2025cites this paper
• Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations

  2025cites this paper
• Formyl peptide receptor 2 activation by mitochondrial formyl peptides stimulates the neutrophil proinflammatory response via the ERK pathway and exacerbates ischemia–reperfusion injury

  2023cites this paper
• Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models

  2023influential citation
• Total Flavones Isolated from Lycium Barbarum L. Inhibit the Proliferation, Migration and Invasion of GlioblastomaU-87MG Cells by Decreasing Formyl Peptide Receptor 1 Expression

  2021cites this paper
• Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers

  2021cites this paper
• Synthesis and structural elucidation of a series of isoflavones-based on FPR antagonists

  2021cites this paper
• Formyl peptide receptor 1 signaling potentiates inflammatory brain injury

  2021cites this paper
• 1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids from the Octocoral Sinularia leptoclados

  2020cites this paper
• Health benefits of chromones: common ingredients of our daily diet

  2020cites this paper
• Health benefits of chromones: common ingredients of our daily diet

  2020cites this paper
• 2H/4H-Chromenes—A Versatile Biologically Attractive Scaffold

  2020influential citation
• COVID-19 and pneumonia: a role for the uPA/uPAR system

  2020cites this paper
• Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists.

  2019cites this paper
• Suppression of autoreactive T and B lymphocytes by anti‐annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus

  2019cites this paper
• The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.

  2018cites this paper
• FPR1 gene silencing suppresses cardiomyocyte apoptosis and ventricular remodeling in rats with ischemia/reperfusion injury through the inhibition of MAPK signaling pathway

  2018cites this paper
• Targeting formyl peptide receptors to facilitate the resolution of inflammation.

  2018cites this paper
• Modern Trends of Organic Chemistry in Russian Universities

  2018cites this paper
• Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury

  2018cites this paper
• Structure of 7-hydroxy-3-(2-methoxyphenyl)-2-trifluoromethyl-4H-chromen-4-one

  2017cites this paper
• Synthesis of Five‐ and Six‐Membered N‐Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists

  2017influential citation
• 4‐Aroyl‐3‐hydroxy‐5‐phenyl‐1H‐pyrrol‐2(5H)‐ones as N‐formyl peptide receptor 1 (FPR1) antagonists

  2017cites this paper
• The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition

  2017cites this paper
• 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.

  2016cites this paper
• Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015)

  2016cites this paper
• Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

  2016influential citation
• Inhibition of Human Neutrophil Responses by the Essential Oil of Artemisia kotuchovii and Its Constituents.

  2015cites this paper